STK11 (LKB1) immunohistochemistry is a sensitive and specific marker for <i>STK11</i> adnexal tumours
STK11 is a highly sensitive and specific immunohistochemical marker for distinguishing STK11 adnexal tumour from its histological mimics, and can obviate the need for confirmatory molecular studies in the appropriate morphological context.
Authors
- Jelena Mirković (ORCID: https://orcid.org/0000-0003-4042-8389)
- W. Glenn McCluggage (ORCID: https://orcid.org/0000-0001-9178-4370)
- Colin J.R. Stewart (ORCID: https://orcid.org/0000-0002-2165-464X)
- Chrystalle Katte Carreon (ORCID: https://orcid.org/0000-0003-2152-7998)
- David L. Kolin (ORCID: https://orcid.org/0000-0002-7631-6525)
- Amir Dehghani (ORCID: https://orcid.org/0000-0002-7095-6249)
- Brooke E. Howitt (ORCID: https://orcid.org/0000-0002-0309-6680)
- Stephanie Siegmund (ORCID: https://orcid.org/0000-0003-1848-2389)
- Christopher P. Crum (ORCID: https://orcid.org/0000-0001-7746-1436)
- Aarti E. Sharma (ORCID: https://orcid.org/0000-0002-3088-3946)
- Fabíola Medeiros
- Jason L. Hornick (ORCID: https://orcid.org/0000-0001-6475-8345)
- Marisa R. Nucci
Institutions
- Cedars-Sinai Medical Center (US)
- Brigham and Women's Hospital (US)
- Boston Children's Hospital (US)
- Belfast Health and Social Care Trust (GB)
- Sunnybrook Health Science Centre (CA)
- Harvard University (US)
- University of Toronto (CA)
- King Edward Memorial Hospital (AU)
- Health Sciences Centre (CA)
- Stanford Medicine (US)
- Stanford University (US)
Publication Details
- Journal
- Histopathology
- Published
- 2024-08-21
- DOI
- https://doi.org/10.1111/his.15303
- Citations
- 6
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.22
Funders
- Brigham and Women's Hospital
- Dana-Farber/Harvard Cancer Center
- National Institutes of Health
- National Cancer Institute